Basel Medical Group Ltd Ordinary Shares

BMGL | NASDAQ

$5.05

+$0.01 (+0.20%)

Nov 2, 2026, 2:28 PM ET · Market open

Fiscal Year Period Ending	FY 2024 Jun 30, 2025	FY 2023 Jun 30, 2024	FY 2022 Jun 30, 2023	FY 2021 Jun 30, 2022
Net Income	-12.51M	2.4M	2.13M	2.39M
Depreciation & Amortization	1.18M	528.73K	557.13K	575.92K
Stock-Based Compensation	n/a	n/a	n/a	n/a
Other Working Capital	4.34M	387.69K	-223.96K	64.49K
Other Non-Cash Items	10.23M	-419.19K	-375.51K	-251.26K
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	-3.25M	-4.82K	286.8K	81.37K
Operating Cash Flow	-4.34M	2.51M	2.6M	2.79M
Capital Expenditures	-54.76K	-7.92K	-6.16K	-88.5K
Cash Acquisitions	-10.99M	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	-11.04M	-7.92K	-6.16K	-88.5K
Debt Repayment	-5.18M	-2.92M	-2.94M	-2.06M
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	12.34M	1.16M	325	-10.86M
Financial Cash Flow	16.91M	-1.77M	-2.94M	-12.92M
Net Cash Flow	1.03M	733.61K	-346.24K	-10.22M
Free Cash Flow	-4.4M	2.5M	2.59M	2.7M
Adj. Free Cash Flow	-4.4M	2.5M	2.59M	2.7M
Maintenance CapEx	n/a	n/a	-6.16K	-88.5K
Growth CapEx	-54.76K	-7.92K	n/a	n/a
Owner Earnings	-4.34M	2.51M	2.59M	2.7M